Location History:
- Shizuoka, JP (2013)
- Okayama, JP (2014)
Company Filing History:
2 out of 59 
2 out of 15 
2 out of 5 
Years Active: 2013-2014
Title: Kenji Matsuno: Innovator in Anticancer Compounds
Introduction
Kenji Matsuno is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. With a total of two patents to his name, Matsuno's work focuses on innovative solutions for cancer treatment.
Latest Patents
Matsuno's latest patents include a 1,3,4-oxadiazole-2-carboxamide compound, which exhibits STAT3 inhibitory activity and is useful as an anticancer agent. This compound is represented by a specific formula, where Ar denotes a furyl group, and R represents a hydrogen atom or similar entities. Another significant patent involves a STAT3 inhibitor that contains a quinolinecarboxamide derivative as its active ingredient. This derivative is characterized by a formula where W can be a bond or an alkylene chain, and X can represent O, S, or NR, with R being various chemical groups.
Career Highlights
Throughout his career, Kenji Matsuno has worked with reputable organizations such as Pharmadesign, Inc. and Shizuoka Prefecture. His experience in these companies has allowed him to refine his expertise in drug development and innovation.
Collaborations
Matsuno has collaborated with notable colleagues, including Akira Asai and Naohisa Ogo. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Kenji Matsuno is a distinguished inventor whose work in developing anticancer compounds has the potential to make a significant impact in the medical field. His innovative contributions and collaborations highlight his commitment to advancing cancer treatment solutions.